Market Place
Sourcing Support
Sirtex Medical secures positive approval of SIR-Spheres Y-90 resin microspheres
15 Sep 2022 //
APNEWS
Sirtex Medical, Grand Pharma receives NDA approval of SIR-Spheres Y-90 resin
09 Feb 2022 //
PRNEWSWIRE
Sirtex Medical successful first administration of SIR-Spheres Y-90 resin
11 Oct 2021 //
PRNEWSWIRE
Sirtex Medical announces new SIR-Spheres® DOORwaY-90 Study
22 Mar 2021 //
PRNEWSWIRE
Sirtex Medical receives positive recommendation from (NICE)
26 Feb 2021 //
PRNEWSWIRE
CIRT-EU Registry for SIR-Spheres® Therapy presented at CIRSE 2020 Summit
15 Sep 2020 //
PRNEWSWIRE
Nanospectra Bio nets Sirtex backing for prostate cancer therapy
15 Sep 2020 //
FIERCEBIOTECH
Study of Sirtex SIR-Spheres Y90 resin microspheres followed by Nivolumab therapy
14 Sep 2020 //
BIOSPACE
Sirtex Medical invests in Nanospectra Biosciences
08 Sep 2020 //
BIOSPECTRUMASIA
Sirtex Medical and China Grand announce landmark drug registration
27 Aug 2020 //
PRNEWSWIRE
Sirtex Medical completes enrollment of landmark U.S. RESiN registry
24 Aug 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.